ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HIK Hikma Pharmaceuticals Plc

2,002.00
-10.00 (-0.50%)
14 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -10.00 -0.50% 2,002.00 2,006.00 2,008.00 2,024.00 1,994.00 2,014.00 178,227 16:35:12
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.88B 192M 0.8685 23.12 4.44B
Hikma Pharmaceuticals Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HIK. The last closing price for Hikma Pharmaceuticals was 2,012p. Over the last year, Hikma Pharmaceuticals shares have traded in a share price range of 1,711.00p to 2,222.00p.

Hikma Pharmaceuticals currently has 221,081,676 shares in issue. The market capitalisation of Hikma Pharmaceuticals is £4.44 billion. Hikma Pharmaceuticals has a price to earnings ratio (PE ratio) of 23.12.

Hikma Pharmaceuticals Share Discussion Threads

Showing 1476 to 1500 of 1875 messages
Chat Pages: Latest  63  62  61  60  59  58  57  56  55  54  53  52  Older
DateSubjectAuthorDiscuss
24/2/2022
07:50
Decent results, pretty in line with market, plus a $300m share buy back, which looks a no brainer at these levels.
18bt
23/2/2022
21:10
Yes not an income stock, 2% GSK 5%.But GSK below what it was 25 years ago. So no capital growth in 25 years.
montyhedge
23/2/2022
19:32
Yield of 2% then
robertball
23/2/2022
13:03
Yes I'm looking for 36c dividend.
montyhedge
23/2/2022
13:03
Was able to grab a few earlier this week at 1917 - fingers crossed
scepticalinvestor
23/2/2022
13:02
Results tomorrow
scepticalinvestor
23/2/2022
12:52
Be nice to get above 2000 before close.
netcurtains
23/2/2022
12:36
Interesting little rise.

When you say "Thursday" do you mean tomorrow?

netcurtains
22/2/2022
10:36
Figures Thursday boys I expect another increase in dividend 15 years continuous dividend growth.
montyhedge
22/2/2022
08:03
How many more percentage points will this drop before Thursday’s results?
blue59
18/2/2022
16:23
We shall know next week.
montyhedge
18/2/2022
15:49
Well someone knows something and it doesn’t bode well!
blue59
17/2/2022
13:41
The reason I don't think so trading update 4th November was very good. Unless of course trading gone downhill in a couple of months.
montyhedge
17/2/2022
13:16
Profit warning, lol doubt it, record profits and another increase in the dividend.
montyhedge
16/2/2022
17:25
Results next week.Going to be interesting.Profit warning coming or the fall is just a de-rating move.
brain smiley
16/2/2022
10:32
Overvalued or undervalued?? What do you guys think and why foe each case? share price is at lowest its been in a while....I'm tempted but is it likely to go lower with the markets or can it outperform?? That's the question
laptop15
15/2/2022
11:38
There was a US fund who had a 9.64% been reducing to 4.92%.If someone just keeps trickling them out of course shareprice will fall. Don't know if they have finished.Figures hopefully decent with a increased dividend, this is not a trading share, it's a tuck away forget about it.Could be worst could be in GSK, shareprice below what it was 25 years ago.
montyhedge
15/2/2022
11:15
5 months of relentless downward trend for no discernible reason.
robertball
15/2/2022
10:54
FFS it’s Groundhog Day!
blue59
15/2/2022
09:06
Don't worry figures next week, should be decent another rise in the dividend expected.Their has been a seller from a US fund last couple of months, tricking shares into the market. Hopefully they have finished.
montyhedge
14/2/2022
09:27
I sold out of gsk and bought this hik dog instead...feeling silly
loads2
14/2/2022
08:57
Trading ok make a profit, but still a fact GSK shareprice below what is was 25 years ago. No capital growth in 25 years.
montyhedge
14/2/2022
08:50
You just keep right on deluding yourself with your self contradicting arguments.

I got out (early I suspect) of GSK with a 16% return in a little over 4 months so have no gripe with it

blue59
11/2/2022
14:11
Dividends not everything over time what is your capital appreciation, you like GSK for its 4.9% yield, ok great.But shareprice below what it was 25 years ago, no growth whatsoever in shareprice.
montyhedge
11/2/2022
10:32
Starting to look good value-even the divi which should be increased, is not entirely token at this price. Given their expanding portfolio, esp in the US, should be trading at double this price compared to US peers. Bought this AM for the Sipp.

Given the dire state of the UK market as a trading platform (look at the volumes in the likes of Hik, JDW etc) the share price could go anywhere in the short term but this is a solid, growing business.

cumnor
Chat Pages: Latest  63  62  61  60  59  58  57  56  55  54  53  52  Older